Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered

Detalles Bibliográficos
Autores principales: Deltenre, Pierre, Moreno, Christophe, Trépo, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977066/
https://www.ncbi.nlm.nih.gov/pubmed/33753153
http://dx.doi.org/10.1016/j.jhep.2021.02.036
_version_ 1783667078306201600
author Deltenre, Pierre
Moreno, Christophe
Trépo, Eric
author_facet Deltenre, Pierre
Moreno, Christophe
Trépo, Eric
author_sort Deltenre, Pierre
collection PubMed
description
format Online
Article
Text
id pubmed-7977066
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Association for the Study of the Liver. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-79770662021-03-19 Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered Deltenre, Pierre Moreno, Christophe Trépo, Eric J Hepatol Letter to the Editor European Association for the Study of the Liver. Published by Elsevier B.V. 2021-10 2021-03-19 /pmc/articles/PMC7977066/ /pubmed/33753153 http://dx.doi.org/10.1016/j.jhep.2021.02.036 Text en © 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Deltenre, Pierre
Moreno, Christophe
Trépo, Eric
Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
title Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
title_full Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
title_fullStr Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
title_full_unstemmed Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
title_short Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered
title_sort progressive cholangiopathy in covid-19 patients: other possible diagnoses than ketamine-induced cholangiopathy should be considered
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977066/
https://www.ncbi.nlm.nih.gov/pubmed/33753153
http://dx.doi.org/10.1016/j.jhep.2021.02.036
work_keys_str_mv AT deltenrepierre progressivecholangiopathyincovid19patientsotherpossiblediagnosesthanketamineinducedcholangiopathyshouldbeconsidered
AT morenochristophe progressivecholangiopathyincovid19patientsotherpossiblediagnosesthanketamineinducedcholangiopathyshouldbeconsidered
AT trepoeric progressivecholangiopathyincovid19patientsotherpossiblediagnosesthanketamineinducedcholangiopathyshouldbeconsidered

Ejemplares similares